Pan-cancer characterization of CHP1 identifies its role in tumor progression and immune microenvironment remodeling
Eurasian Journal of Medicine and Oncology · 27.04.2026 · 025470489
DOI: 10.36922/ejmo025470489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 27.04.2026. Verfasst von Cui-Fang Han und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Calcineurin B homologous protein 1 (CHP1), a crucial cofactor of the sodium–hydrogen exchanger 1 (NHE1), plays a pivotal role in triglyceride synthesis and storage within the endoplasmic reticulum. Increasing evidence suggests that CHP1 participates in biological processes central to tumorigenesis.
Objective
This study aims to systematically investigate the expression profile of CHP1 across multiple human cancers through a pan-cancer analysis and evaluate its associations with clinical outcomes and immune cell infiltration through integrated bioinformatics approaches.
Methods
Expression and clinical data from 33 cancer types were obtained from The Cancer Genome Atlas and Genotype-Tissue Expression (GTEx) databases. Analyses of CHP1 expression levels, tissue distribution, stage-specific variation, prognostic value, diagnostic performance, gene alterations, immune infiltration, protein–protein interactions, and enrichment pathways were performed using the Human Protein Atlas, Gene Expression Profiling Interactive Analysis 2, Tumor Immune Estimation Resource 2, and Search Tool for the Retrieval of Interacting Genes/Proteins platforms.
Results
CHP1 expression was significantly downregulated in 11 tumor types compared with corresponding adjacent normal tissues. Higher CHP1 expression was associated with a favorable prognosis in several cancer types and demonstrated high diagnostic accuracy.
Conclusion
CHP1 is frequently downregulated across multiple cancers and is closely linked to patient survival, supporting its potential as a prognostic biomarker. Its significant association with immune infiltration suggests a potential role in modulating the tumor immune microenvironment, highlighting CHP1 as a promising therapeutic target in pan-cancer settings.
Zitieren
APA
Han, C., Zhu, R., & Liu, X. (2026). Pan-cancer characterization of CHP1 identifies its role in tumor progression and immune microenvironment remodeling. Eurasian Journal of Medicine and Oncology, 0(0), 025470489. https://doi.org/10.36922/ejmo025470489
Vancouver
Han C, Zhu R, Liu X. Pan-cancer characterization of CHP1 identifies its role in tumor progression and immune microenvironment remodeling. Eurasian Journal of Medicine and Oncology. 2026;0(0):025470489. doi:10.36922/ejmo025470489
BibTeX
@article{Han2026,
author = {Han, Cui-Fang and Zhu, Ri-Ting and Liu, Xiao-Min},
title = {Pan-cancer characterization of CHP1 identifies its role in tumor progression and immune microenvironment remodeling},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {025470489},
doi = {10.36922/ejmo025470489}
}
EUVIMED